Eosinophilic esophagitis (EoE) is a chronic disease of the esophagus. Your esophagus is the muscular tube that carries food and liquids from your mouth to the stomach. If you have EoE, white blood cells called eosinophils build up in your esophagus. This causes damage and inflammation, which can cause pain, trouble swallowing, and food getting stuck in your throat.
EoE is rare. But because it is a newly recognized disease, it is being diagnosed more often. Some people who think that they have reflux (GERD) may actually have EoE.
Researchers are not certain about the exact cause of EoE. They think that it is an immune system/allergic reaction to foods or to substances in your environment, such as dust mites, animal dander, pollen, and molds. Certain genes may also play a role in EoE.
EoE can affect anyone, but it is more common in people who:
The most common symptoms of EoE can depend on your age.
In infants and toddlers::
In older children::
In adults::
To find out if you have EoE, your doctor will likely:
There is no cure for EoE. Treatments can manage your symptoms and prevent further damage. The two main types of treatments are medicines and diet.
Medicines used to treat EoE are:
Dietary changes for EoE include:
Which treatment your doctor suggests depends on different factors, including your age. Some people may use more than one kind of treatment. Researchers are still trying to understand EoE and how best to treat it.
If your treatment is not working well enough and you have narrowing of the esophagus, you may need dilation. This is a procedure to stretch the esophagus. This makes it easier for you to swallow.
Source: MedlinePlus, National Library of Medicine.
MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.
Biologics
Dupilumab (Dupixent) is an injectable medication called a monoclonal antibody (or biologic) that is administered weekly. It reduces the inflammation associated with the disease and improves patients’ ability to swallow food. It is approved by the U.S. Food and Drug Administration (FDA) to treat people with EoE, ages 1 and older. This medication blocks the signaling of IL-4 and IL-13, two cytokines involved in inflammation. This medication may help improve dysphagia symptoms and be effective in patients who don’t respond to other therapies. Dupixent® is administered via a subcutaneous injection (under the skin). Source: Sanofi Regeneron
Topical Steroids
Budesonide Oral Suspension (EOHILIA) is the first and only FDA-approved oral therapy for people 11 years and older with eosinophilic esophagitis (EoE). EOHILIA is indicated for 12 weeks of treatment in adult and pediatric patients 11 years of age and older with eosinophilic esophagitis (EoE). Source: Takeda
Shared-Decision Making Made Easy: Jump Start the Conversation with Your Healthcare Provider.
Are you living eosinophilic esophagitis (EoE) and not responding to current treatment or dietary interventions? Not sure how to talk with your doctor about your symptoms or ask about other treatment options? Then this online tool is for you!
Your answers to these questions can help your healthcare provider better understand your symptoms and quality of life with EoE. Once you complete this brief questionnaire, your answers will be emailed to you for easy sharing with your healthcare provider.
Use this tool to prepare for a productive conversation with your doctor about:
Listen to our
latest Podcast!